Chemogenetic Manipulation of Amygdala Kappa Opioid Receptor Neurons Modulates Amygdala Neuronal Activity and Neuropathic Pain Behaviors

Guangchen Ji,Peyton Presto,Takaki Kiritoshi,Yong Chen,Edita Navratilova,Frank Porreca,Volker Neugebauer

DOI: https://doi.org/10.3390/cells13080705

IF: 6

2024-04-20

Cells

Abstract:Neuroplasticity in the central nucleus of the amygdala (CeA) plays a key role in the modulation of pain and its aversive component. The dynorphin/kappa opioid receptor (KOR) system in the amygdala is critical for averse-affective behaviors in pain conditions, but its mechanisms are not well understood. Here, we used chemogenetic manipulations of amygdala KOR-expressing neurons to analyze the behavioral consequences in a chronic neuropathic pain model. For the chemogenetic inhibition or activation of KOR neurons in the CeA, a Cre-inducible viral vector encoding Gi-DREADD (hM4Di) or Gq-DREADD (hM3Dq) was injected stereotaxically into the right CeA of transgenic KOR-Cre mice. The chemogenetic inhibition of KOR neurons expressing hM4Di with a selective DREADD actuator (deschloroclozapine, DCZ) in sham control mice significantly decreased inhibitory transmission, resulting in a shift of inhibition/excitation balance to promote excitation and induced pain behaviors. The chemogenetic activation of KOR neurons expressing hM3Dq with DCZ in neuropathic mice significantly increased inhibitory transmission, decreased excitability, and decreased neuropathic pain behaviors. These data suggest that amygdala KOR neurons modulate pain behaviors by exerting an inhibitory tone on downstream CeA neurons. Therefore, activation of these interneurons or blockade of inhibitory KOR signaling in these neurons could restore control of amygdala output and mitigate pain.

cell biology

What problem does this paper attempt to address?

The paper primarily explores the impact of specifically manipulating κ-opioid receptor (KOR) expressing neurons within the central amygdala (CeA) on pain behavior in a chronic neuropathic pain model using chemogenetic methods.

Research Background:
- Chronic pain is a global health issue encompassing multiple dimensions such as sensory, emotional-affective, and cognitive aspects. Current treatment methods are limited in effectiveness and have significant side effects.
- The amygdala, particularly the CeA region, plays a crucial role in the emotional-affective component of pain and pain modulation.
- The KOR system is associated with negative emotional behaviors, but its specific mechanisms within the amygdala are not fully understood.

Research Objectives:
- To investigate the effects of specifically activating or inhibiting KOR-expressing neurons within the CeA on the behavior and electrophysiological characteristics of mice in a chronic neuropathic pain model using chemogenetic methods.

Main Findings:
1. **Chemogenetic inhibition of CeA-KOR neurons** induced pain-like behaviors (such as decreased mechanical pain threshold and increased anxiety-like behavior) in normal mice but had no significant effect in mice with established neuropathic pain.
2. **Chemogenetic activation of CeA-KOR neurons** alleviated pain-related behaviors (such as increased mechanical pain threshold and reduced ultrasonic vocalizations) in neuropathic pain mice, suggesting that activating these neurons may help alleviate pain.

In summary, this study reveals the functional dynamics of the CeA-KOR system and its potential role in pain modulation, providing a theoretical basis for developing new strategies to treat chronic neuropathic pain.